Latest Insider Transactions at Cyteir Therapeutics, Inc. (CYT)
This section provides a real-time view of insider transactions for Cyteir Therapeutics, Inc. (CYT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Cyteir Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Cyteir Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 20
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
170,589
+4.46%
|
$341,178
$2.95 P/Share
|
|
Mar 18
2024
|
Braden Michael Leonard |
BUY
Open market or private purchase
|
Indirect |
113,777
+3.16%
|
$341,331
$3.01 P/Share
|
|
Mar 04
2024
|
Markus Md Renschler President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,304
+0.57%
|
$6,304
$1.69 P/Share
|
|
Mar 04
2024
|
David G Gaiero Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,373
+2.27%
|
$2,373
$1.69 P/Share
|
|
Feb 29
2024
|
Markus Md Renschler President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,144
+0.68%
|
$15,144
$1.45 P/Share
|
|
Feb 29
2024
|
David G Gaiero Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,985
+3.91%
|
$7,985
$1.69 P/Share
|
|
Feb 14
2024
|
Jean George Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,150
+50.0%
|
$14,150
$1.69 P/Share
|
|
Feb 09
2024
|
Stephen H. Sands Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,129
+50.0%
|
$12,129
$1.69 P/Share
|
|
Feb 08
2024
|
John F Thero Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,828
+35.98%
|
$12,828
$1.69 P/Share
|
|
Feb 06
2024
|
Joseph S Zakrzewski Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,150
+5.86%
|
$14,150
$1.69 P/Share
|
|
Dec 11
2023
|
David G Gaiero Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,993
+2.14%
|
$3,993
$1.69 P/Share
|
|
Nov 20
2023
|
Markus Md Renschler President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
93,477
+2.12%
|
$93,477
$1.45 P/Share
|
|
Nov 20
2023
|
David G Gaiero Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
73,940
+31.81%
|
$73,940
$1.69 P/Share
|
|
Jul 20
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
100,000
-2.76%
|
$200,000
$2.75 P/Share
|
|
Jul 19
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,900
-0.05%
|
$3,800
$2.76 P/Share
|
|
Jul 18
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,500
-0.18%
|
$13,000
$2.76 P/Share
|
|
Jul 17
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
21,100
-0.58%
|
$42,200
$2.75 P/Share
|
|
Jul 14
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,000
-0.3%
|
$22,000
$2.74 P/Share
|
|
Jun 30
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
200,937
-5.2%
|
$401,874
$2.63 P/Share
|
|
Jun 27
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
31,978
-0.82%
|
$31,978
$1.77 P/Share
|
|
Jun 26
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,437
-0.22%
|
$8,437
$1.79 P/Share
|
|
Jun 23
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,423
-0.09%
|
$3,423
$1.88 P/Share
|
|
Jun 22
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,041
-0.13%
|
$5,041
$1.94 P/Share
|
|
Jun 21
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,834
-0.12%
|
$4,834
$1.99 P/Share
|
|
Jun 20
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
744
-0.02%
|
$1,488
$2.11 P/Share
|
|
Jun 16
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,983
-0.15%
|
$11,966
$2.03 P/Share
|
|
Jun 15
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,002
-0.25%
|
$20,004
$2.03 P/Share
|
|
Jun 14
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,872
-0.07%
|
$5,744
$2.11 P/Share
|
|
Jun 13
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,626
-0.07%
|
$5,252
$2.1 P/Share
|
|
Jun 12
2023
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
900
-0.02%
|
$1,800
$2.06 P/Share
|
|
Jan 13
2023
|
David G Gaiero Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+35.46%
|
$5,000
$1.49 P/Share
|
|
Jan 13
2023
|
Markus Md Renschler President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+0.51%
|
$5,000
$1.49 P/Share
|
|
Dec 21
2022
|
Markus Md Renschler President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
136,782
+6.55%
|
$136,782
$1.12 P/Share
|
|
Dec 07
2022
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
21,202
+12.06%
|
$21,202
$1.3 P/Share
|
|
Jul 20
2022
|
Novo Holdings > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
900,000
-18.59%
|
$2,700,000
$3.0 P/Share
|
|
May 12
2022
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
743
+0.55%
|
$743
$1.61 P/Share
|
|
May 11
2022
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.75%
|
$1,000
$1.7 P/Share
|
|
May 10
2022
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
49,406
+27.28%
|
$49,406
$1.89 P/Share
|
|
May 10
2022
|
John F Thero Director |
BUY
Open market or private purchase
|
Direct |
10,000
+50.0%
|
$20,000
$2.0 P/Share
|
|
Dec 28
2021
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
601
+0.73%
|
$5,409
$9.85 P/Share
|
|
Dec 27
2021
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
299
+0.18%
|
$2,990
$10.08 P/Share
|
|
Dec 23
2021
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
200
+0.25%
|
$1,800
$9.87 P/Share
|
|
Dec 20
2021
|
David G Gaiero Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,100
+50.0%
|
$4,100
$1.68 P/Share
|
|
Dec 17
2021
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
200
+0.25%
|
$1,800
$9.88 P/Share
|
|
Dec 15
2021
|
Joseph S Zakrzewski Director |
BUY
Open market or private purchase
|
Direct |
3,700
+2.26%
|
$37,000
$10.8 P/Share
|
|
Jun 22
2021
|
Jean George Director |
BUY
Conversion of derivative security
|
Indirect |
2,444,268
+50.0%
|
-
|
|
Jun 22
2021
|
Janwillem Naesens Director |
BUY
Open market or private purchase
|
Indirect |
277,777
+7.28%
|
$4,999,986
$18.0 P/Share
|
|
Jun 22
2021
|
Janwillem Naesens Director |
BUY
Conversion of derivative security
|
Indirect |
3,259,026
+50.0%
|
-
|
|
Jun 22
2021
|
Timothy Romberger Director |
BUY
Conversion of derivative security
|
Direct |
79,060
+17.63%
|
-
|
|
Jun 22
2021
|
Joseph S Zakrzewski Director |
BUY
Conversion of derivative security
|
Indirect |
58,671
+50.0%
|
-
|